Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

CHD2 Knockout K562 Polyclonal Cells

CHD2 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The CHD2 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19273

CNP Knockout K562 Polyclonal Cells

CNP Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The CNP was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19272

DENND4A Knockout K562 Polyclonal Cells

DENND4A Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The DENND4A was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19270

DENND6A Knockout K562 Polyclonal Cells

DENND6A Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The DENND6A was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19269

DES Knockout K562 Polyclonal Cells

DES Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The DES was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19268

CSRP2 Knockout K562 Polyclonal Cells

CSRP2 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The CSRP2 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19267

PCCA Knockout K562 Polyclonal Cells

PCCA Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The PCCA was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19266

LYSMD3 Knockout K562 Polyclonal Cells

LYSMD3 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The LYSMD3 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19265

CHD9 Knockout K562 Polyclonal Cells

CHD9 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The CHD9 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19264

MPI Knockout K562 Polyclonal Cells

MPI Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The MPI was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19263

LDLRAD3 Knockout K562 Polyclonal Cells

LDLRAD3 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The LDLRAD3 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19262

FIZ1 Knockout K562 Polyclonal Cells

FIZ1 Knockout K562 Polyclonal Cells is a knockout polyclonal cell population. The FIZ1 was knocked out in the K562 cells using the CRISPR RNP technique.
Cat. No. ARG19261

Loading products...